Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

56 ta ish

Ish: Dihydromyricetin: A potential candidate for the treatment of cholestatic liver injury via inhibition of the NLRP3 inflammasome

  1. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

    Jianjin Shi, Yue Zhao, Kun Wang +7

    Maqola20154 iqtibos
    ABI

  2. Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability

    Dan Liu, Yiqin Mao, Lijun Ding +1

    Sharh maqolaOchiq kirish20193 iqtibos
    ABI

  3. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy

    Tingjuan Ni, Na Lin, Wenqiang Lu +4

    Maqola20203 iqtibos
    ABI

  4. Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism

    Joshua Silva, Xin Yu, Renita Moradian +6

    MaqolaOchiq kirish20203 iqtibos
    ABI

  5. A role for mitochondria in NLRP3 inflammasome activation

    Rongbin Zhou, Amir S. Yazdi, Philippe Menu +1

    Maqola20103 iqtibos
    ABI

  6. Mechanisms of hepatic stellate cell activation

    Takuma Tsuchida, Scott L. Friedman

    Sharh maqola20173 iqtibos
    ABI

  7. Dihydromyricetin regulates the miR-155-5p/SIRT1/VDAC1 pathway to promote liver regeneration and improve alcohol-induced liver injury

    Qing Ma, Shuo Huang, Mei-ya Li +13

    Maqola20253 iqtibos
    ABI

  8. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease

    G. Paumgartner, Ulrich Beuers

    Sharh maqola20042 iqtibos
    ABI

  9. Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1

    Zhenzhu Sun, Wenqiang Lu, Na Lin +6

    Maqola20202 iqtibos
    ABI

  10. Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA‐21 in apolipoprotein E‐deficient mice

    Dafeng Yang, Zhousheng Yang, Lei Chen +15

    MaqolaOchiq kirish20202 iqtibos
    ABI

  11. Dihydromyricetin ameliorates chronic liver injury by reducing pyroptosis

    Quancheng Cheng, Jing Fan, Xin-Wei Deng +6

    MaqolaOchiq kirish20202 iqtibos
    ABI

  12. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism

    Sijing Dong, Min Zhu, Ke Wang +5

    Maqola20212 iqtibos
    ABI

  13. Dihydromyricetin alleviates Escherichia coli lipopolysaccharide-induced hepatic injury in chickens by inhibiting the NLRP3 inflammasome

    Chenxi Shi, Jiaqi Wang, Ruichen Zhang +7

    MaqolaOchiq kirish20222 iqtibos
    ABI

  14. Dihydromyricetin prevents obesity <i>via</i> regulating bile acid metabolism associated with the farnesoid X receptor in <i>ob</i>/<i>ob</i> mice

    Yanjun Song, Le Sun, Pei Ma +2

    Maqola20222 iqtibos
    ABI

  15. Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway

    Xiaoqi Li, Xin Wang, Binyu Wang +7

    Maqola20222 iqtibos
    ABI

  16. Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease

    Hang Gong, Huimei Xu, Muyang Li +1

    Sharh maqola20222 iqtibos
    ABI

  17. Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis

    Zheming Xu, Minjing Zhang, Wenwen Wang +19

    Maqola20232 iqtibos
    ABI

  18. Preparation, characterization and protective effect of chitosan - Tripolyphosphate encapsulated dihydromyricetin nanoparticles on acute kidney injury caused by cisplatin

    Qiaohua Yan, Meiqing Li, Liying Dong +12

    Maqola20232 iqtibos
    ABI

  19. Modulation of keap-1/Nrf2/HO-1 and NF-ĸb/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury

    Doaa Emad, Asmaa M. A. Bayoumi, Sahar M. Gebril +2

    Maqola20242 iqtibos
    ABI

  20. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition

    Rebecca C. Coll, James R. Hill, Christopher J. Day +8

    Maqola20192 iqtibos
    ABI

  21. Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages

    Cornelius Y. Taabazuing, Marian C. Okondo, Daniel A. Bachovchin

    Maqola20172 iqtibos
    ABI

  22. Estrogen accelerates the resolution of inflammation in macrophagic cells

    Alessandro Villa, Nicoletta Rizzi, Elisabetta Vegeto +2

    Maqola20152 iqtibos
    ABI

  23. Sex differences in immune responses

    Sabra L. Klein, Katie L. Flanagan

    Sharh maqola20162 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa2 iqtibos
    ABI